Rivaroxaban

Details

Files

Generic Name:

Rivaroxaban

Project Status:

Complete

Therapeutic Area:

Thromboembolism (venous), prevention

Manufacturer:

Bayer Inc.

Brand Name:

Xarelto

Project Line:

Reimbursement Review

Project Number:

SR0134-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Thromboembolism (venous), prevention

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

December 17, 2008

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : May 7, 2008